MDxHealth, HistoGeneX Collaborate on PharmacoMDx Testing Services | GenomeWeb

NEW YORK (GenomeWeb News) – MDx Health and HistoGeneX today announced a collaboration to provide molecular diagnostic testing services to drug manufacturers and oncologists.

Under the terms of the deal, MDxHealth will combine its epigenetics technologies with HistoGeneX's pharmacodiagnostic services. HistoGeneX's laboratory in Belgium will also provide MGMT methylation service testing for MDxHealth's clients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.